Amedisys Financial Statements (AMED)
|
|
|
|
Report date
|
|
|
25.02.2021 |
24.02.2022 |
16.02.2023 |
26.04.2024 |
27.02.2025 |
|
30.07.2025 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
2 072 |
2 214 |
2 223 |
2 236 |
2 348 |
|
2 402 |
|
Operating Income, bln rub |
|
|
219.3 |
251.9 |
180.8 |
156.4 |
94.5 |
|
99.6 |
|
EBITDA, bln rub |
? |
|
250.7 |
320.7 |
207.4 |
216.9 |
73.4 |
|
164.7 |
|
Net profit, bln rub |
? |
|
183.6 |
209.1 |
118.6 |
-9.75 |
43.2 |
|
149.7 |
|
|
OCF, bln rub |
? |
|
289.0 |
188.9 |
133.3 |
137.2 |
221.7 |
|
239.4 |
|
CAPEX, bln rub |
? |
|
5.33 |
6.72 |
7.22 |
12.7 |
7.37 |
|
5.25 |
|
FCF, bln rub |
? |
|
283.6 |
182.2 |
126.1 |
124.5 |
214.3 |
|
234.2 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
|
|
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
662.7 |
728.8 |
779.0 |
834.5 |
923.1 |
|
1 286 |
|
Cost of production, bln rub |
|
|
1 185 |
1 233 |
1 260 |
1 246 |
1 331 |
|
1 147 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
3.00 |
3.80 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
11.0 |
9.53 |
22.2 |
31.3 |
30.8 |
|
27.6 |
|
|
Assets, bln rub |
|
|
1 567 |
1 857 |
1 976 |
2 060 |
2 139 |
|
2 215 |
|
Net Assets, bln rub |
? |
|
809.2 |
931.4 |
1 052 |
1 067 |
1 135 |
|
1 233 |
|
Debt, bln rub |
|
|
307.0 |
545.6 |
537.9 |
487.2 |
460.2 |
|
451.4 |
|
Cash, bln rub |
|
|
81.8 |
42.7 |
40.5 |
126.5 |
303.2 |
|
337.3 |
|
Net debt, bln rub |
|
|
225.2 |
502.9 |
497.4 |
360.8 |
156.9 |
|
114.1 |
|
|
Ordinary share price, rub |
|
|
293.3 |
161.9 |
|
|
90.8 |
|
98.4 |
|
Number of ordinary shares, mln |
|
|
32.6 |
32.6 |
32.5 |
32.5 |
32.7 |
|
32.8 |
|
|
Market cap, bln rub |
|
|
9 551 |
5 284 |
0 |
0 |
2 970 |
|
3 232 |
|
EV, bln rub |
? |
|
9 776 |
5 787 |
497 |
361 |
3 127 |
|
3 346 |
|
Book value, bln rub |
|
|
-198 |
-376 |
-337 |
-281 |
-161 |
|
-61 |
|
|
EPS, rub |
? |
|
5.64 |
6.40 |
3.65 |
-0.30 |
1.32 |
|
4.56 |
|
FCF/share, rub |
|
|
8.71 |
5.58 |
3.88 |
3.83 |
6.55 |
|
7.13 |
|
BV/share, rub |
|
|
-6.07 |
-11.5 |
-10.4 |
-8.64 |
-4.91 |
|
-1.84 |
|
|
EBITDA margin, % |
? |
|
12.1% |
14.5% |
9.33% |
9.70% |
3.13% |
|
6.85% |
|
Net margin, % |
? |
|
8.86% |
9.44% |
5.34% |
-0.44% |
1.84% |
|
6.23% |
|
FCF yield, % |
? |
|
2.97% |
3.45% |
|
|
7.21% |
|
7.25% |
|
ROE, % |
? |
|
22.7% |
22.4% |
11.3% |
-0.91% |
3.81% |
|
12.1% |
|
ROA, % |
? |
|
11.7% |
11.3% |
6.00% |
-0.47% |
2.02% |
|
6.76% |
|
|
P/E |
? |
|
52.0 |
25.3 |
0.00 |
0.00 |
68.7 |
|
21.6 |
|
P/FCF |
|
|
33.7 |
29.0 |
0.00 |
0.00 |
13.9 |
|
13.8 |
|
P/S |
? |
|
4.61 |
2.39 |
0.00 |
0.00 |
1.26 |
|
1.35 |
|
P/BV |
? |
|
-48.3 |
-14.1 |
0.00 |
0.00 |
-18.5 |
|
-53.3 |
|
EV/EBITDA |
? |
|
39.0 |
18.0 |
2.40 |
1.66 |
42.6 |
|
20.3 |
|
Debt/EBITDA |
|
|
0.90 |
1.57 |
2.40 |
1.66 |
2.14 |
|
0.69 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
41.6% |
29.9% |
0.00% |
|
0.00% |
|
|
CAPEX/Revenue, % |
|
|
0.26% |
0.30% |
0.32% |
0.57% |
0.31% |
|
0.22% |
|
| Amedisys shareholders |
